January
Celtic Catalysts to attend Informex 2009 in Moscone Center, San Francisco, USA January 27-30th
February
Celtic Catalysts opens large-scale development and production unit in UK.
4th February, Dublin, IRELAND. Dublin company Celtic Catalysts today announced that it has opened a subsidiary company in the United Kingdom. Based in Wilton, Redcar in the Northeast of England the new site will house the company’s large scale production and development activities.
Speaking at the official opening of the unit, CEO Brian Kelly said “This marks the next step in the ongoing development and success of Celtic Catalysts”. Operations Director Geoffrey Fuller added “The addition of this facility enables us to meet the demand for larger quantities of our products. It also means we can develop, pilot and optimize robust manufacturing processes which we can then transfer either directly back to our customers or to their manufacturer of choice”
About Celtic Catalysts
Celtic Catalysts was established in Ireland in 2000 with a mission to develop products and processes which underpin the manufacture of high-value products in the Pharmaceutical, Biotechnology and Fine Chemicals industries. Since its formation, the company has developed ground-breaking chemistry which its uses to provide its clients in the Pharmaceutical, Biotech and Fine Chemicals industries with products and services which enable them to realize significant manufacturing cost savings. Since formation, the company has grown steadily and now houses an R&D team in Dublin, Ireland and a production team in Wilton, UK. This enables the company to provide its products from laboratory to production scale. In addition the company has onsite access to the full spectrum of analytical tools - NMR, MS, GC, HPLC and X-ray crystallography.
March
Stella James joins the Celtic Catalysts management team.
March 18th 2009, Dublin, IRELAND. Dublin company Celtic Catalysts today announced the addition of Dr. Stella James to their management team. As Celtic Catalysts enters its next phase of expansion Dr. James will head up the Sales division of the company. She brings with her a wealth of experience and insights having started her career as a process chemist and later working in business development and sales positions in both European and US based companies.
In welcoming her to the company, Brian Kelly, CEO said “This is an exciting time for Celtic Catalysts as we continue to add to our portfolio of products and services. Stella is a fantastic addition to our team and her vibrancy, enthusiasm and can-do attitude perfectly mirrors that of the company”
Dr. James in turn commented “I am thrilled to be joining such an innovative company and look forward to working with my very talented colleagues”
About Celtic Catalysts
Celtic Catalysts was established in Ireland in 2000 with a mission to develop products and processes which underpin the manufacture of high-value products in the Pharmaceutical, Biotechnology and Fine Chemicals industries. Since its formation, the company has developed ground-breaking chemistry which its uses to provide its clients in the Pharmaceutical, Biotech and Fine Chemicals industries with products and services which enable them to realize significant manufacturing cost savings. Since formation, the company has grown steadily and now houses an R&D team in Dublin, Ireland and a production team in Wilton, UK. This enables the company to provide its products from laboratory to production scale. In addition the company has onsite access to the full spectrum of analytical tools - NMR, MS, GC, HPLC and X-ray crystallography.
June
Celtic Catalysts will be attending Chemspec Europe in Barcelona, Spain. June 17-19th
September
Celtic Catalysts will be attending Pharma ChemOutsourcing Conference & Exhibition at the Ocean Place Resort New Jersey. September 14-16th
October
Celtic Catalysts will be attending CPhI in Madrid, Spain. October 13-15th
November
Celtic Catalysts announces the launch of the world’s best asymmetric hydrogenation catalyst.
November 18th 2009, Dublin, IRELAND. Dublin company Celtic Catalysts today announced the launch of a new catalyst based upon its proprietary P-chiral Cel-PHOS P* ligand. With particular application in the hydrogenation of enamides to form amino acids the rhodium complex of the Cel-PHOS P* ligand routinely gives 99.5% ee with spectacularly low catalyst loadings (substrate to catalyst loadings of >100,000:1).
Commenting on this new development, Chief Scientific Officer Declan Gilheany said “I have been involved in the development of a number of successful catalysts and catalytic systems in the past, but this catalyst is by far the most impressive in terms of its ease of use and the selectivity and turnover numbers it achieves. I am looking forward to the continued expansion of its range of industrially useful applications”
About Celtic Catalysts
Celtic Catalysts was established in Ireland in 2000 with a mission to develop products and processes which underpin the manufacture of high-value products in the Pharmaceutical, Biotechnology and Fine Chemicals industries. Since its formation, the company has developed ground-breaking chemistry which its uses to provide its clients in the Pharmaceutical, Biotech and Fine Chemicals industries with products and services which enable them to realize significant manufacturing cost savings. Since formation, the company has grown steadily and now houses an R&D team in Dublin, Ireland and a production team in Wilton, UK. This enables the company to provide its products from laboratory to production scale. In addition the company has onsite access to the full spectrum of analytical tools - NMR, MS, GC, HPLC and X-ray crystallography.